Xiamen Amoytop Biotech Statistics

Total Valuation

Xiamen Amoytop Biotech has a market cap or net worth of CNY 30.02 billion. The enterprise value is 29.44 billion.

Market Cap	30.02B
Enterprise Value	29.44B

Important Dates

The last earnings date was Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Xiamen Amoytop Biotech has 406.80 million shares outstanding. The number of shares has increased by 1.35% in one year.

Current Share Class	n/a
Shares Outstanding	406.80M
Shares Change (YoY)	+1.35%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	50.86%
Owned by Institutions (%)	13.55%
Float	110.49M

Valuation Ratios

The trailing PE ratio is 40.55 and the forward PE ratio is 29.62. Xiamen Amoytop Biotech's PEG ratio is 0.99.

PE Ratio	40.55
Forward PE	29.62
PS Ratio	11.57
PB Ratio	13.26
P/TBV Ratio	n/a
P/FCF Ratio	218.12
P/OCF Ratio	n/a
PEG Ratio	0.99

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 32.12, with an EV/FCF ratio of 213.94.

EV / Earnings	39.75
EV / Sales	11.35
EV / EBITDA	32.12
EV / EBIT	34.55
EV / FCF	213.94

Financial Position

The company has a current ratio of 4.32, with a Debt / Equity ratio of 0.00.

Current Ratio	4.32
Quick Ratio	3.43
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.07
Interest Coverage	1,731.44

Financial Efficiency

Return on equity (ROE) is 37.46% and return on invested capital (ROIC) is 26.81%.

Return on Equity (ROE)	37.46%
Return on Assets (ROA)	22.10%
Return on Capital (ROIC)	26.81%
Revenue Per Employee	1.32M
Profits Per Employee	377,904
Employee Count	1,960
Asset Turnover	1.08
Inventory Turnover	0.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +73.26% in the last 52 weeks. The beta is 0.45, so Xiamen Amoytop Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+73.26%
50-Day Moving Average	71.48
200-Day Moving Average	60.65
Relative Strength Index (RSI)	46.25
Average Volume (20 Days)	2,431,954

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Xiamen Amoytop Biotech had revenue of CNY 2.60 billion and earned 740.69 million in profits. Earnings per share was 1.82.

Revenue	2.60B
Gross Profit	2.42B
Operating Income	852.17M
Pretax Income	838.73M
Net Income	740.69M
EBITDA	911.20M
EBIT	852.17M
Earnings Per Share (EPS)	1.82

Full Income Statement

Balance Sheet

The company has 584.55 million in cash and 9.90 million in debt, giving a net cash position of 574.65 million or 1.41 per share.

Cash & Cash Equivalents	584.55M
Total Debt	9.90M
Net Cash	574.65M
Net Cash Per Share	1.41
Equity (Book Value)	2.26B
Book Value Per Share	5.57
Working Capital	1.16B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 421.16 million and capital expenditures -283.54 million, giving a free cash flow of 137.62 million.

Operating Cash Flow	421.16M
Capital Expenditures	-283.54M
Free Cash Flow	137.62M
FCF Per Share	0.34

Full Cash Flow Statement

Margins

Gross margin is 93.08%, with operating and profit margins of 32.84% and 28.54%.

Gross Margin	93.08%
Operating Margin	32.84%
Pretax Margin	32.32%
Profit Margin	28.54%
EBITDA Margin	35.11%
EBIT Margin	32.84%
FCF Margin	5.30%

Dividends & Yields

This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 0.55%.

Dividend Per Share	0.41
Dividend Yield	0.55%
Dividend Growth (YoY)	92.49%
Years of Dividend Growth	4
Payout Ratio	22.52%
Buyback Yield	-1.35%
Shareholder Yield	-0.80%
Earnings Yield	2.47%
FCF Yield	0.46%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Xiamen Amoytop Biotech has an Altman Z-Score of 34.79.

Altman Z-Score	34.79
Piotroski F-Score	n/a